NPI 1669170650: Open Payments
NPI 1669170650. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 9 payments from 2 companies in 2025. Trend: 2023 $2,007 · 2024 $2,148 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $137 |
| Ardelyx, Inc. | 3 | $74 |
Products named: IBSRELA.
